|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0560 EUR | -2.10% |
|
+1.08% | +10.24% |
| 03-30 | Neolife SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-09-29 | Neolife SA Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
Company Valuation: Neolife
Data adjusted to current consolidation scope
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 2.878 | 6.866 | 23.36 | 16.13 | 3.687 | 6.929 |
| Change | - | 138.54% | 240.27% | -30.95% | -77.14% | 87.91% |
| Enterprise Value (EV) 1 | 3.787 | 7.143 | 23.31 | 17 | 4.341 | 7.35 |
| Change | - | 88.61% | 226.3% | -27.07% | -74.46% | 69.33% |
| P/E | -1.43x | -8.1x | -45.2x | -95.3x | -1.87x | -13.2x |
| PBR | 1.73x | 3.27x | 10.9x | 7.24x | 1.41x | 1.61x |
| PEG | - | 0.1x | 0.9x | 1.4x | -0x | 0.2x |
| Capitalization / Revenue | 0.4x | 0.79x | 2.88x | 1.46x | 0.27x | 0.52x |
| EV / Revenue | 0.53x | 0.83x | 2.87x | 1.53x | 0.32x | 0.55x |
| EV / EBITDA | -4.65x | -15.6x | 68.8x | 118x | -4.85x | 49.3x |
| EV / EBIT | -2.55x | -11.3x | -68.3x | 1,953x | -4.21x | -13.9x |
| EV / FCF | -9.73x | -18.3x | 55.1x | -15.6x | -7.71x | - |
| FCF Yield | -10.3% | -5.47% | 1.82% | -6.41% | -13% | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.07 | -0.02 | -0.01 | -0.003233 | -0.0376 | -0.005432 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 7.198 | 8.655 | 8.126 | 11.09 | 13.55 | 13.43 |
| EBITDA 1 | -0.8147 | -0.4572 | 0.3389 | 0.1444 | -0.8945 | 0.1491 |
| EBIT 1 | -1.482 | -0.6331 | -0.3414 | 0.008702 | -1.03 | -0.5289 |
| Net income 1 | -1.859 | -0.9307 | -0.5163 | -0.1693 | -3.625 | -0.5235 |
| Net Debt 1 | 0.9088 | 0.2768 | -0.0553 | 0.8645 | 0.6534 | 0.4211 |
| Reference price 2 | 0.1000 | 0.1620 | 0.4520 | 0.3080 | 0.0704 | 0.0719 |
| Nbr of stocks (in thousands) | 28,783 | 42,382 | 51,687 | 52,378 | 52,378 | 96,371 |
| Announcement Date | 6/25/20 | 6/25/20 | 4/5/22 | 4/5/22 | 4/28/23 | 4/29/24 |
1EUR in Million2EUR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 6.14M | ||
| 16.98x | 2.01x | 9.61x | 1.57% | 66.73B | ||
| 30.79x | 4.89x | 16.16x | 0.75% | 36.29B | ||
| 35.55x | 3.66x | 18.76x | 0.94% | 36.19B | ||
| 13.15x | 1.57x | 7.19x | 2.31% | 33.63B | ||
| 29.57x | 5.34x | 15.69x | 0.62% | 33.6B | ||
| 18.63x | 2.47x | 9.45x | 1.3% | 27.27B | ||
| 21.36x | 6.27x | 13.61x | 2.04% | 21.89B | ||
| 81.59x | 4.45x | 83.53x | 0.32% | 21.76B | ||
| 11.72x | 1.31x | 6.45x | 0.83% | 17.54B | ||
| Average | 28.82x | 3.55x | 20.05x | 1.19% | 29.49B | |
| Weighted average by Cap. | 26.89x | 3.39x | 17.50x | 1.24% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALNLF Stock
- Valuation Neolife
Select your edition
All financial news and data tailored to specific country editions
















